13 min listen
Regression predicts Sentinel Lymph Node (SLN) status
FromModPath Chat
ratings:
Length:
18 minutes
Released:
Sep 14, 2021
Format:
Podcast episode
Description
The prognostic significance of regression has long been a matter of debate. Our guest, Professor Richard Scolyer, co-director of the Melanoma Institute Australia discussed his team’s recent findings on the prognostic value of regression, and the presence of regression and/or tumor infiltrating lymphocytes (TIL) in primary cutaneous melanomas predicted sentinel lymph node (SLN) status and survival outcomes. Study by Scolyer et al, Histological regression in melanoma: impact on sentinel lymph node status and survival. Modern Pathology, 2021. https://www.nature.com/articles/s41379-021-00870-2. Our GDPR privacy policy was updated on August 8, 2022. Visit acast.com/privacy for more information.
Released:
Sep 14, 2021
Format:
Podcast episode
Titles in the series (58)
A novel tumor type with EWSR-CREB fusions blending features of Angiomatoid FH and Mesothelioma: A novel tumor type with EWSR-CREB fusions blending features of Angiomatoid FH and Mesothelioma; a discussion with the author Pedram Argani. by ModPath Chat